Bristol Inventory Issues Include High Supply Of Glucophage IR

Bristol-Myers Squibb's new approach to wholesaler inventory levels should help the company capture more of the benefit from product price increases, CEO Peter Dolan suggested during an April 25 earnings conference call

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet